500 patients67,039 observations150 daysLIVE

Patient P-03360

Synthetic patientONX-7 · Day 142 · 35–44 · M · baseline S10Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
9%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S10
  2. Day 31 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 104 NP-02 recommendedDietary Support Protocol NP-02
  4. Day 105 Patient acceptedStarted NP-02 in the companion
  5. Day 115 No meaningful changeDietary Support Protocol NP-02

What changed?

Trajectory began diverging from predicted response on Day 31.

Primary contributors, last 14 days
  • GI instability-4
  • Nutritional resilience+3
  • Inflammatory activity-2
  • Treatment adherence-2

What helped?

  • Dietary Support Protocol NP-02Day 104
    Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level
Daily log
6.5/10
improving · +0.4 vs previous 14 d
Stress level
Daily log
3.4/10
improving · -0.3 vs previous 14 d
Pessimism score
Daily log
4.6/10
stable · +0.0 vs previous 14 d
Sleep quality
Wearable
41.3/100
improving · +2.2 vs previous 14 d
Libido
Daily log
5.2/10
improving · +0.3 vs previous 14 d
HRV
Wearable
52.5 ms
improving · +2.1 vs previous 14 d
Toxicity
Blood
5.3/100
improving · -0.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 69 from the failing basin, 46 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -2.6 next day on high-intake days · n 21
Would not help
  • AD-05 Adherence Support
    only 29% improved among 14 similar
  • NP-02 Dietary Support Protocol
    already tried, no meaningful change
  • Keep lactose low
    GI +2.6 next day on high-intake days · n 18
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Lactose
    +2.6detractor · 91%
  • Protein
    -2.6supporter · 95%
  • Dietary fat load
    -1.2no signal · 45%
  • Alcohol
    +0.9no signal · 33%
  • Caffeine
    -0.3no signal · 15%
  • Histamine load
    +0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Butyrate / short-chain fatty acid production 25
    • MicrobiomeF. prausnitzii depleted
  • Inflammatory signalling 20
    • MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 3.6 · butyrate capacity 55/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
50 ms
Sleep
6.4 h
Steps
5,523
Resting HR
59 bpm
Daily log: GI score 17, nutritional resilience 72, adherence 89.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0310445%S14AD-05no change27
P-0336941%S18AD-05no change37
P-0303440%S14AD-05no change30
P-0338037%S16AD-05improved34
P-0312236%S13AD-05no change40
P-0315836%S17AD-05no change37
P-0312935%S18AD-05no change32
P-0342435%S12AD-05improved41
P-0311134%S07AD-05no change48
P-0320432%S16AD-05improved48
P-0344130%S19AD-05improved37
P-0335128%S07AD-05no change51